Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ebzZCfbwoceVjAfNtSVy

December 7, 2012
Sign upForwardArchiveAdvertise
News for physicians caring for the seriously ill

  Top Story 
  • Study considers whether to give IV fluids to patients near death
    A recent study sheds some light on whether IV or subcutaneous fluids should be avoided at the end of life to prevent fluid buildup and if doing so leads to delirium, Dr. Eric Widera writes. Research in the Journal of Clinical Oncology found no significant differences between patients with IV hydration and without in terms of dehydration symptoms or overall delirium scores. The study included 129 patients with mild to moderate but not severe dehydration. GeriPal blog (12/5) LinkedInFacebookTwitterEmail this Story
Is Pricing Low Your Strategy to Success? Think again.
Pricing is the heart of a business. It affects everything you do and is affected by everything you do. Economists talk of supply and demand as key factors behind pricing—successful entrepreneurs manipulate demand by making their products more desirable. These six steps will help you determine the right price for your product or service, read the article and learn how to get pricing right.

  Palliative & Hospice Care Update  
 
  • Targeted therapy may delay end-of-life transition, study finds
    Targeted therapies such as bevacizumab, erlotinib, sorafenib and rituximab are increasingly are used in advanced cancer patients at the end of life, according to research from the University of Texas MD Anderson Cancer Center. The study team wrote in the Journal of Pain and Symptom Management these treatments are used about as often as chemotherapy and could delay a transition in care, "diverting patients' precious time and energy to the pursuit of cancer treatments rather than planning ahead." MedWire News (U.K.) (12/6) LinkedInFacebookTwitterEmail this Story
  • Other News
Building Workplace Trust 2015
Interaction Associates' 6th annual research study tracking trust on the job, Building Workplace Trust, is out, and more than half of employees surveyed give their organizations low marks for trust and leadership. Yet this year's findings again point to how high trust leads to better outcomes and financial results — and even boosts innovation.

  Patient & Family Perspective  
 
  • Other News
How to Achieve IT Agility: A Survival Guide for IT Decision Makers
When business teams add new apps and services to already-strained networks, IT departments are accountable for making everything work. Is your team ready for this challenge? Read this eGuide to learn how IT teams are automating their networks, why they're utilizing Ethernet fabrics and SDN, and what success looks like as they regain network control and business relevance.

  Medical Research  
  • Positive attitude toward pain increases tolerance, study says
    An Italian study found patients who had a positive or beneficial approach to pain had higher tolerances. The study, reported in the journal Pain, highlights the importance of the meaning of pain in patients' perception of it. "Therefore, the behavioral and/or pharmacological manipulation of the meaning of pain can represent an effective approach to pain management," a researcher wrote. MedWire News (U.K.) (12/5) LinkedInFacebookTwitterEmail this Story
  • 10 years of tamoxifen better to prevent breast cancer, study finds
    Women using tamoxifen to prevent a recurrence of breast cancer had better protection if they took the drug for 10 years instead of the standard five, Oxford University researchers reported in The Lancet. Breast cancer experts said the data, which showed a lower recurrence rate among women who took the drug longer, also may have implications for postmenopausal women who usually take other medications to prevent a recurrence. The New York Times (tiered subscription model) (12/5) LinkedInFacebookTwitterEmail this Story
  Health Policy & Practice  
  • FDA expresses confidence in reviews of generic drugs
    The FDA's approval process for generic drugs, including approvals based on extrapolated data, is safe and reliable, Center for Drug Evaluation and Research Director Dr. Janet Woodcock and other FDA officials wrote in an article in the New England Journal of Medicine. The agency withdrew approval for 300-milligram bupropion after finding it did not perform similarly to the 150-mg dose upon which approval was based. Medscape (free registration) (12/5) LinkedInFacebookTwitterEmail this Story
  Trends & Technology  
  • Platform allows patient monitoring via live video chat
    AT&T has unveiled a cloud-based remote patient-monitoring platform designed to enable physicians to better monitor their patients' chronic conditions, including diabetes, via video chat. Video chatting may allow clinicians to observe signs of problems such as mood and skin color changes that they would not be able to note through a phone conversation, according to an AT&T official. eWeek (12/5) LinkedInFacebookTwitterEmail this Story
  AAHPM News  
  • Are you following best practices in your billing and coding?
    Participate in this webinar, sponsored by the American Academy of Hospice and Palliative Medicine on Dec. 11 at 2 p.m. Eastern Time and learn the best practices in billing and coding for providers in hospice and palliative care, as well as what triggers a billing audit, the difference between billing by time versus complexity, the basics of billing and coding and common pitfalls, and the importance of having a compliance program. LinkedInFacebookTwitterEmail this Story
  • Opioid REMS and safe use practices: What are the implications today?
    Learn about risk evaluation and mitigation strategies associated with long-acting and extended-release opioids. This online activity, developed by CO*RE, in partnership with Medscape, offers CME/CE credit for learners. No fee required. Learn more. LinkedInFacebookTwitterEmail this Story
  SmartQuote  
You will never find time for anything. If you want time you must make it."
--Charles Buxton,
British brewer, philanthropist, writer and legislator


LinkedInFacebookTwitterEmail this Story

 
This newsletter is brought to you by the American Academy of Hospice and Palliative Medicine and SmartBrief.
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Senior Account Director:  Aaron Kern 202-407-7866
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent Hospice and Palliative Medicine SmartBrief Issues:   Lead Editor:  Tom Parks
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information